572 related articles for article (PubMed ID: 32633660)
1. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
2. Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic.
Defoe KD; Jupp J; Leslie T
J Oncol Pharm Pract; 2019 Apr; 25(3):607-612. PubMed ID: 29451420
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.
Kaya M; Nakamura K; Nagamine M; Suyama Y; Nakajo M; Uchida R; Hagikura K; Kanda A; Sugiyama K; Sugiyama R; Nakagaki S; Kimura M
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1371. PubMed ID: 33739629
[TBL] [Abstract][Full Text] [Related]
4. Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
Oliveira CS; Silva MP; Miranda ÍKSPB; Calumby RT; de Araújo-Calumby RF
J Oncol Pharm Pract; 2021 Apr; 27(3):679-692. PubMed ID: 33302824
[TBL] [Abstract][Full Text] [Related]
5. Impact of outpatient interventions made at an ambulatory cancer centre oncology pharmacy in Singapore.
Chew C; Chiang J; Yeoh TT
J Oncol Pharm Pract; 2015 Apr; 21(2):93-101. PubMed ID: 24477774
[TBL] [Abstract][Full Text] [Related]
6. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
7. Specializing in pediatric hematology and oncology.
Beavers MB
Am J Health Syst Pharm; 2007 Apr; 64(8):812-3. PubMed ID: 17420194
[No Abstract] [Full Text] [Related]
8. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Clinical Pharmacists on Readmission Rates of Heart Failure Patients in the Accountable Care Environment.
Schumacher C; Moaddab G; Colbert M; Kliethermes MA
J Manag Care Spec Pharm; 2018 Aug; 24(8):795-799. PubMed ID: 30058987
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center.
Tuffaha HW; Abdelhadi O; Omar SA
Int J Clin Pharm; 2012 Feb; 34(1):27-31. PubMed ID: 22207272
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.
Shah S; Dowell J; Greene S
Ann Pharmacother; 2006 Sep; 40(9):1527-33. PubMed ID: 16882869
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
Lau KM; Saunders IM; Sacco AG; Barnachea LC
J Oncol Pharm Pract; 2020 Sep; 26(6):1390-1396. PubMed ID: 31937188
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
Arnold ME; Buys L; Fullas F
Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
[TBL] [Abstract][Full Text] [Related]
14. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
15. Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic.
Mancini R
J Support Oncol; 2012; 10(3):99-106. PubMed ID: 22266155
[TBL] [Abstract][Full Text] [Related]
16. The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation.
Martin JE; Zavala EY
Clin Transplant; 2004; 18 Suppl 12():50-4. PubMed ID: 15217408
[TBL] [Abstract][Full Text] [Related]
17. Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.
Ignoffo RJ; Knapp KK; Seung A; Brown V; Hough S; Rieband G; Dang TO; Palumbo A; Urmanski A
J Oncol Pharm Pract; 2021 Jan; 27(1):5-13. PubMed ID: 32237957
[TBL] [Abstract][Full Text] [Related]
18. Building an outpatient cancer center pharmacy program across a tristate region.
Skledar SJ; Doedyns A; Yourich B
Am J Health Syst Pharm; 2015 Jan; 72(2):126-32. PubMed ID: 25550136
[TBL] [Abstract][Full Text] [Related]
19. The Expanding Role of the Oncology Pharmacist.
Holle LM; Segal EM; Jeffers KD
Pharmacy (Basel); 2020 Jul; 8(3):. PubMed ID: 32722357
[TBL] [Abstract][Full Text] [Related]
20. Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
Booth JP; Kennerly-Shah JM; Kelley LR; Capozzi D; Prescott HA; Soefje SA; Pace MB; Barbour SY; Tizon RF; DeVincenzo S; Carnes CA; Neidecker MV
J Oncol Pharm Pract; 2023 Dec; 29(8):1907-1914. PubMed ID: 36803319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
